The Pharmacokinetics, Safety and Tolerability of Aclidinium Bromide 400 μg Administered by Inhalation as Single and Multiple (Twice Daily) Doses in Healthy Chinese Participants

PURPOSE: To date, aclidinium pharmacokinetic (PK) studies have focused on Caucasian populations, and no data are available for Chinese populations. We aimed to characterize the PK and safety profile of aclidinium and its metabolites (LAS34823 and LAS34850) following single and multiple (twice-daily;...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Weimin, Daoud, Sami Z, Trivedi, Roopa, Lukka, Pradeep B, Jimenez, Eulalia, Molins, Eduard, Stewart, Catherine, Bharali, Pranob, Garcia-Gil, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691958/
https://www.ncbi.nlm.nih.gov/pubmed/38046981
http://dx.doi.org/10.2147/COPD.S434588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691958/
https://www.ncbi.nlm.nih.gov/pubmed/38046981
http://dx.doi.org/10.2147/COPD.S434588

Ejemplares similares